Compare RTO & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RTO | ZBH |
|---|---|---|
| Founded | 1925 | 1927 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.6B | 18.9B |
| IPO Year | 2002 | 2001 |
| Metric | RTO | ZBH |
|---|---|---|
| Price | $22.78 | $94.61 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 21 |
| Target Price | $35.00 | ★ $101.00 |
| AVG Volume (30 Days) | 1.4M | ★ 1.6M |
| Earning Date | 03-09-2026 | 04-28-2026 |
| Dividend Yield | ★ 1.60% | 1.20% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.25 |
| Revenue | N/A | ★ $8,231,500,000.00 |
| Revenue This Year | $17.05 | $4.96 |
| Revenue Next Year | $4.35 | $3.76 |
| P/E Ratio | $222.16 | ★ $41.88 |
| Revenue Growth | N/A | ★ 7.20 |
| 52 Week Low | $23.07 | $79.12 |
| 52 Week High | $34.67 | $106.88 |
| Indicator | RTO | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 30.65 | 42.24 |
| Support Level | N/A | $94.28 |
| Resistance Level | $24.22 | $97.92 |
| Average True Range (ATR) | 0.38 | 2.61 |
| MACD | 0.12 | -0.93 |
| Stochastic Oscillator | 1.17 | 28.12 |
Rentokil Initial is the largest global provider of route-based pest control and commercial hygiene services, operating in over 90 countries, with its largest operations in the United States following the acquisition of Terminix. The group also offers a range of specialist route-based services, including office and commercial space plant care, property care, and workwear rentals. The group serves a diverse client base of global food producers, hotel chains, industrial goods companies, restaurants, and individual residential customers.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.